VSV-ZEBOV vaccination
VSV-ZEBOV immunization
VSV-EBOVAC
humans clinical studies of VSV
clinical development
Ebola vaccine development
Vaccine safety
clinical trials
single dose of VSV
vaccine manufacturer
clinical samples
vectored Zaire Ebola vaccine
capacity of various doses of VSV
promising new Ebola vaccine candidate
promising vaccine candidates
main clinical sites
Ebola Zaire infections
immunogenicity signatures of human responses
development of novel
adaptive immune responses
Switzerland
metabolomics signatures
Gabon
Kenya
consortium
World Health Organization
determinants of persistent immune responses
critical knowledge gap
cutting-edge technologies
world-leaders
organization of parallel
powerful immunisation technologies
non-human primates
Public Health Canada
vesicular stomatitis virus
specific emphasis
large FP7
scientists
volunteers
partners of ADITEC
NewLink Genetics
long-lasting protective efficacy
trancriptomics
collaborative research programme
proposal
depth characterization
immunology
antibody
man Phase
representatives
months
generation vaccines
African populations
ambitious program
asset
Europe
primary objectives
topic
IMI2
aim
information